Duration of Anticoagulation After Cerebral Venous Sinus Thrombosis

被引:19
作者
Caprio, Frances [1 ]
Bernstein, Richard A. [1 ]
机构
[1] Northwestern Univ, Dept Neurol, Stroke Program, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
Cerebral venous sinus thrombosis; Oral anticoagulation; Duration; Recurrence; Venous thromboembolis; DEEP-VEIN THROMBOSIS; INTERNATIONAL CONSENSUS STATEMENT; INTENSITY WARFARIN THERAPY; LONG-TERM PROGNOSIS; FACTOR-V-LEIDEN; RISK-FACTORS; PROTHROMBIN-GENE; PULMONARY-EMBOLISM; 1ST EPISODE; ANTIPHOSPHOLIPID SYNDROME;
D O I
10.1007/s12028-011-9661-1
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Cerebral venous sinus thrombosis (CVST) often occurs in young patients and is treated with acute and then long-term oral anticoagulation. It is important to decide when to discontinue anticoagulation, as lifelong anticoagulation exposes the patient to considerable cumulative risk. However, a lack of high quality studies makes choosing a duration of anticoagulation after CVST difficult. In this article, we review the evidence for different treatment durations in several common clinical scenarios of CVST. In addition, when no direct evidence is available, we discuss and extrapolate from the more comprehensively studied situation of systemic venous thromboembolic disease. Recommendations are graded using standard criteria for the level of evidence.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 82 条
[1]
Extended oral anticoagulant therapy after a first episode of pulmonary embolism [J].
Agnelli, G ;
Prandoni, P ;
Becattini, C ;
Silingardi, M ;
Taliani, MR ;
Miccio, M ;
Imberti, D ;
Poggio, R ;
Ageno, W ;
Pogliani, E ;
Porro, F ;
Zonzin, P .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (01) :19-25
[2]
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].
Agnelli, G ;
Prandoni, P ;
Santamaria, MG ;
Bagatella, P ;
Iorio, A ;
Bazzan, M ;
Moia, M ;
Guazzaloca, G ;
Bertoldi, A ;
Tomasi, C ;
Scannapieco, G ;
Ageno, W ;
Ascani, A ;
Villalta, S ;
Frulla, M ;
Mosena, L ;
Girolami, A ;
Vaccarino, A ;
Alatri, A ;
Palareti, G ;
Marchesi, M ;
Ambrosio, GB ;
Parisi, R ;
Doria, S ;
Steidl, L ;
Ambrosini, F ;
Silingardi, M ;
Ghirarduzzi, A ;
Iori, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169
[3]
CEREBRAL VENOUS THROMBOSIS [J].
AMERI, A ;
BOUSSER, MG .
NEUROLOGIC CLINICS, 1992, 10 (01) :87-111
[4]
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[5]
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study [J].
Baglin, T ;
Luddington, R ;
Brown, K ;
Baglin, C .
LANCET, 2003, 362 (9383) :523-526
[6]
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy [J].
Bates, Shannon M. ;
Greer, Ian A. ;
Pabinger, Ingrid ;
Sofaer, Shoshanna ;
Hirsh, Jack .
CHEST, 2008, 133 (06) :844S-886S
[7]
Recanalisation of cerebral venous thrombosis [J].
Baumgartner, RW ;
Studer, A ;
Arnold, M ;
Georgiadis, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (04) :459-461
[8]
Limited knowledge on progestogen-only contraception and risk of venous thromboembolism [J].
Bergendal, Annica ;
Odlind, Viveca ;
Persson, Ingemar ;
Kieler, Helle .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (03) :261-266
[9]
Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems [J].
Bombeli, T ;
Basic, A ;
Fehr, J .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (02) :126-132
[10]
Heparin treatment in acute cerebral sinus venous thrombosis: A retrospective clinical and MR analysis of 42 cases [J].
Brucker, AB ;
Vollert-Rogenhofer, H ;
Wagner, M ;
Stieglbauer, K ;
Felber, S ;
Trenkler, J ;
Deisenhammer, E ;
Aichner, F .
CEREBROVASCULAR DISEASES, 1998, 8 (06) :331-337